Ulisse Biomed S.p.A. (BIT:UBM)
0.7600
+0.0100 (1.33%)
Apr 28, 2025, 11:42 AM CET
Ulisse Biomed Revenue
In the year 2024, Ulisse Biomed had annual revenue of 767.93K EUR with 1,059.87% growth. Ulisse Biomed had revenue of 397.07K in the half year ending December 31, 2024, with 431.07% growth.
Revenue
767.93K
Revenue Growth
+1,059.87%
P/S Ratio
23.91
Revenue / Employee
95.99K
Employees
10
Market Cap
18.36M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Recordati Industria Chimica e Farmaceutica | 2.34B |
DiaSorin | 1.19B |
Amplifon | 2.41B |
Philogen | 77.65M |
EL.En. | 565.85M |
Pharmanutra | 116.15M |
Garofalo Health Care | 467.77M |
Safilo Group | 993.22M |